$IDRA Headlines 4 stocks to watch 3:42 p.m. March 19,

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2014 at 9:41 AM

$IDRA Headlines

4 stocks to watch 3:42 p.m. March 19, 2014 - The Trading Deck
Charting the backdrop ahead of the Fed 11:13 a.m. March 19, 2014 - Michael Ashbaugh
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
Bears chip away at the S&P 1,775 support 12:01 p.m. Feb. 3, 2014 - Michael Ashbaugh
Charting a bullish early-2014 outlook 1:05 p.m. Dec. 31, 2013 - Michael Ashbaugh
Charting a bullish early-2014 outlook 12:39 p.m. Dec. 31, 2013 - Michael Ashbaugh
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Pfizer, Affymetrix weigh on drug stocks 3:04 p.m. July 7, 2011 - Val Brickates Kennedy
Idera tumbles 14% on drug setback 2:52 p.m. July 7, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:37 p.m. Jan. 19, 2010 - MarketWatch
Incyte, Idera move on Novartis deals 3:02 p.m. Nov. 25, 2009 - Val Brickates Kennedy
Novartis terminates pact with Idera 9:28 a.m. Nov. 25, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:29 p.m. Dec. 26, 2007 - MarketWatch
Idera Pharmaceuticals' president, Karr, resigns 10:08 a.m. Dec. 26, 2007 - Robert Daniel
Idera Pharma President Karr resigns, stays on board 10:03 a.m. Dec. 26, 2007 - Robert Daniel
Idera signs agonist licensing, collaboration with Merck KGaA 8:10 a.m. Dec. 19, 2007 - Sarah Turner
Idera to get up to $381 mln in milestones 8:03 a.m. Dec. 19, 2007 - Steve Goldstein
Idera, Merck KGaA agree collaboration deal 8:02 a.m. Dec. 19, 2007 - Steve Goldstein
Wednesday's biggest stock gainers and decliners 7:03 p.m. Feb. 28, 2007 - Michael Baron

Insider Buying On The Rise At These 5 Stocks With Earnings Next Week 4:33 p.m. May 8, 2014 - TheStreet.com
Abbott to develop molecular diagnostic test for Indera 9:01 a.m. May 8, 2014 - Seeking Alpha
Will Idera Pharmaceuticals (IDRA) Stock Sustain Today's Rally? 1:21 p.m. April 22, 2014 - TheStreet.com
Interesting IDRA Put And Call Options For June 21st 1:11 p.m. April 22, 2014 - TheStreet.com
Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA) 10:10 a.m. April 11, 2014 - TheStreet.com
Idera +5% AH on positive IMO-8400 data 5:24 p.m. April 7, 2014 - Seeking Alpha
Idera Soars on Phase II Drug Data - Analyst Blog 5:06 p.m. March 31, 2014 - Zacks.com
Idera up big premarket 9:11 a.m. March 28, 2014 - Seeking Alpha
Idera slumps 4:21 p.m. March 24, 2014 - Seeking Alpha
Idera: A Compelling Biotech Pick For March 11:34 a.m. March 7, 2014 - Seeking Alpha
3 Small Cap Biotechs With Near-Term Catalysts 10:25 a.m. March 6, 2014 - Seeking Alpha
Idera Pharmaceuticals: Set To Ride A 200% Gain In 2014 10:38 a.m. Jan. 31, 2014 - Seeking Alpha
Idera Pharmaceuticals Presents a Promising Opportunity 3:23 p.m. Dec. 26, 2013 - Wall St. Cheat Sheet
Friday’s Biggest Stock Losers: INSY OPK, and More 8:52 a.m. Dec. 13, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 7:00 a.m. Dec. 11, 2013 - InvestorPlace.com
10-Q: IDERA PHARMACEUTICALS, INC. 8:02 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech-Focused Baker Bros. Accumulates These 3 Stocks 9:55 a.m. Oct. 1, 2013 - Seeking Alpha
Idera Phase 2 Data Provides For Exciting Q4 2013 And Q1 2014 9:02 a.m. Sept. 25, 2013 - Seeking Alpha
Analysts: Blackstone Mortgage Gaining Traction and 3 Other Research Notes to Browse 2:37 p.m. Aug. 29, 2013 - Wall St. Cheat Sheet
10-Q: IDERA PHARMACEUTICALS, INC. 7:49 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)

Idera Pharmaceuticals to Participate in a Panel Discussion at the Piper Jaffray GenomeRx Symposium 8:00 a.m. June 17, 2014 - BusinessWire - BZX
Idera Pharmaceuticals to Present at the Nucleic Acid Summit 2014 4:25 p.m. June 13, 2014 - BusinessWire - BZX
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 6:50 a.m. May 29, 2014 - PR Newswire - PRF
Idera Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference 8:31 a.m. May 28, 2014 - BusinessWire - BZX
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Idera Pharmaceuticals Reports First Quarter 2014 Financial Results and Provides Update on Key Programs and Business Strategy 7:01 a.m. May 13, 2014 - BusinessWire - BZX
Idera Announces Agreement with Abbott to Develop a Companion Diagnostic for IMO-8400 in Genetically Defined Forms of B-cell Lymphoma 8:31 a.m. May 8, 2014 - BusinessWire - BZX
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma 8:00 a.m. May 7, 2014 - PR Newswire - PRF
Idera Pharmaceuticals to Host Conference Call and Webcast to Report First Quarter 2014 Financial Results and Provide a Detailed Pipeline Review 8:31 a.m. May 6, 2014 - BusinessWire - BZX
Idera Expands Management Team with Three Key Hires 8:31 a.m. May 5, 2014 - BusinessWire - BZX
U.S. District Court Judge Nixes Banning of Zogenix's Painkiller in Massachusetts 10:42 a.m. April 21, 2014 - ACCESSWIRE
Top Gainers Technical Data -- Research on BioScrip, E-House China Holdings, MagneGas, and Idera Pharma 8:47 a.m. April 9, 2014 - PR Newswire - PRF
Idera Presents Preclinical Data at AACR Showing IMO-8400 Inhibits Tumor Growth and Survival Signaling in B-cell Lymphoma Cells with Oncogenic MYD88 L265P Mutation 4:06 p.m. April 7, 2014 - BusinessWire - BZX
Patient Enrollment, Acquisitions, FDA Reviews, and Results of Earnings and Clinical Trials - Analyst Notes on Arrowhead, Providence, Durata, Orthofix, and Idera 8:00 a.m. April 4, 2014 - PR Newswire - PRF
BlackBerry Wins Preliminary Injunction against Ryan Seacrest's Typo Products; Red Hat Tumbles on Weak Guidance 12:17 a.m. March 31, 2014 - ACCESSWIRE
Idera Pharmaceuticals Announces Positive Top-line Data in Phase 2 Trial of IMO-8400 7:15 a.m. March 28, 2014 - BusinessWire - BZX
New Highs & Stocks to Watch -- Research on Penn Virginia, Idera Pharma, US Geothermal, and First Republic Bank 8:23 a.m. March 19, 2014 - PR Newswire - PRF
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial Results and Provides Corporate Update 7:51 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Expansion of Pipeline into Two Orphan Autoimmune Diseases 7:35 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Appointment of Julian Baker and Dr. Kelvin Neu to its Board of Directors 8:31 a.m. March 12, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Why Ghosts Don’t Spook Homebuyers Anymore

By Caleb Price Updated Oct 28, 2026 Category News Views 145

Haunted Houses—A New Norm in Real Estate? In what's becoming a spooky trend in real estate, more than half of Americans are game for buying haunted houses. Imagine that! Suddenly, Casper and his ghostly pals are claiming space in the housing market. With home prices soaring, folks are getting creative. Could a phantasmal presence really tip the scales for cash-strapped...

Flex LNG Readies for Crucial Q3 Earnings Reveal

Anticipation Builds for Flex LNG's Upcoming Q3 Reveal The air's thick with expectation as Flex LNG gears up to lay its cards on the table for the third quarter of 2026. Come November 11, the company will spill the beans on its financial dance over the last few months, promising to unfurl the numbers early in the morning like a farmer checking crops at dawn—07:00 CET...

JumpCloud Tackles Compliance in the AI Era

By Kelly Martin Updated Oct 28, 2026 Category News Views 131

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

SoftwareOne Triumphs in 2026 GitHub Partner Awards

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Proton Therapy: A Game-changer in Breast Cancer Treatment

Understanding the Radiation Conundrum When it comes to breast cancer, there's no sugarcoating it—the diagnosis alone can shake the foundation of anyone's life. But once the dust settles, another layer of decisions begins. One of the trickiest questions patients face is, "What radiation options are out there?" That's where proton therapy comes in, and it's high time we...

Factory-Built Homes Take Center Stage in New Doc Short

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Bluevua Partners with Orlando Solar Bears

Bluevua Takes Aim at Bigger Waters Bluevua's move to partner with the Orlando Solar Bears ain't just some casual sponsorship. It’s a statement, loud and clear, that they're ready to play in the big leagues. By sliding into this relationship, they’re not only flexing their branding muscles but also tapping into a vibrant sports market. It’s a clever game plan to...

Seasonal Hiring Booms as Firms Eye Long-Term Talent

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

PZZA Faces Class Action Over Misleading Sales Outlook

Who's Pointing Fingers at Papa John's? Papa John's International, Inc. (NASDAQ: PZZA) is now headlining a courtroom drama that sounds as crispy as their pizza crust. Last ditch deadline's pinned for November 2, 2026, for grabbing the top spot as lead plaintiff against Papa John’s top brass, Todd Allan Penegor and former CFO Ravi Thanawala. These head honchos reportedly...

Heritage Wines Meet Non-Alcoholic Trend: New Deal

Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...